Filter
3273
Filtered Results: 3273
Text search:
WHO
drug
use
indicators
Featured
Recommendations
274
New Publications
1007
Language
Document type
No document type
2108
Studies & Reports
502
Guidelines
334
Manuals
126
Strategic & Response Plan
126
Training Material
28
Fact sheets
24
Situation Updates
16
Infographics
7
Brochures
1
Online Courses
1
Countries / Regions
India
199
Kenya
116
Global
107
Ethiopia
92
Uganda
90
Nepal
81
Tanzania
78
Nigeria
76
Malawi
75
Western and Central Europe
69
South Africa
67
Zambia
64
Sierra Leone
63
Liberia
60
Ghana
57
Bangladesh
54
Latin America and the Carribbean
53
Myanmar / Burma
52
Rwanda
45
Namibia
41
Africa
39
Ukraine
33
Zimbabwe
33
Eastern Europe
33
Philippines
31
Lesotho
29
Cambodia
29
South–East Asia Region
29
Asia
25
Indonesia
21
Botswana
20
Congo, Democratic Republic of
17
Senegal
15
Burkina Faso
15
Eswatini/ Swaziland
15
Mozambique
14
Cameroon
11
Russia
11
Haiti
10
Eastern Europe and Central Asia
10
East and Southern Africa
10
Pakistan
10
Colombia
9
Syria
9
Albania
9
Georgia
9
Venezuela
8
West and Central Africa
8
Brazil
8
Middle East and North Africa
7
Thailand
6
Moldova
6
South Sudan
6
Laos
5
Peru
5
Guinea
5
Germany
5
Lebanon
5
Sudan
5
North Macedonia
4
Tajikistan
4
Benin
4
China
4
Armenia
4
USA
4
Western Pacific Region
4
North America
4
Argentina
4
Vietnam
4
Timor Leste/ East Timor
3
Mexico
3
El Salvador
3
Chile
3
Afghanistan
3
Jordan
3
Bolivia
3
Papua New Guinea
3
Sri Lanka
3
Bhutan
3
Iraq
3
Turkey
2
Kazakhstan
2
Iran
2
Estonia
2
Kyrgyzstan
2
Morocco
2
Mongolia
2
Saudi Arabia
2
Paraguay
2
Turkmenistan
2
France
2
United Kingdom
2
Portugal
2
Spain
2
Côte d’Ivoire / Ivory Coast
2
Central African Republic
2
Honduras
2
Mali
2
North Korea
1
Serbia
1
Gambia
1
Fiji
1
Singapore
1
Congo-Brazzaville
1
Niger
1
Qatar
1
Bulgaria
1
Italy
1
Hungary
1
Ireland
1
Gabon
1
Uruguay
1
Jamaica
1
Belgium
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Belarus
1
Nicaragua
1
Greece
1
Palestine
1
Poland
1
Libya
1
Somalia
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1495
Clinical Guidelines
254
Public Health
182
Women & Child Health
110
Key Resources
108
Pharmacy & Technologies
39
Capacity Building
35
Toolboxes
HIV
384
TB
302
Mental Health
227
AMR
183
NTDs
109
COVID-19
83
Pharmacy
77
Caregiver
66
NCDs
62
Rapid Response
57
Planetary Health
39
Disability
32
Global Health Education
32
Conflict
31
Refugee
27
Ebola & Marburg
25
Health Financing Toolbox
21
Polio
14
Natural Hazards
12
Cholera
11
Specific Hazards
9
Malaria
7
Zika
6
Social Ethics
4
A case study from Bosnia and Herzegovina Eurasian Harm Reduction Network
The case study was prepared by Samir Ibisevic, President of PROI between March and June 2016 and edited by Graham Shaw.
EHRN is grateful to all who contributed to this document, especially: Dr. Serifa Godinjak, Chairperson...
Comprehensive Reviews in Food Science and Food Safety, Vol.12 (2013) pp.234-248
In 2006, the Institute of Food Technologists (IFT) published an Expert Report entitled “Antimicrobial Resistance: Implications for the Food System” (IFT 2006). That report summarized current scientific knowledge pe...
Regional Tuberculosis Program, Pan American Health Organization (PAHO/WHO)
Networking for Policy Change: TB/HIV Participant’s Guide
WHO/HTM/TB/2007.384b
“TB is too often a death sentence for people with AIDS. It does not have to be this
way.”
-Nelson Mandela, International conference on HIV and AIDS, Bangkok, Thailand, July 2004.
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
2018 monitoring report: current status and strategic priorities
The report sets out the status of women’s, children’s and adolescents’ health, and on health systems and social and environmental determinants. Regional dashboards on 16 key indicators highlight where progress is being made o...
The report sets out the status of women’s, children’s and adolescents’ health, and on health systems and social and environmental determinants. Regional dashboards on 16 key indicators highlight where progress is being made o...
Antimicrobials have been a critical public health tool since the discovery of penicillin in 1928, saving the lives of millions of people around the world. Today, however, the emergence of drug resistance is reversing the miracles of the past eighty years, with drug choices for the treatment of many ...
The TB section of the toolkit presents selected (a) programmatic output and (b) outcome and impact indicators for TB. In addition to recommended monitoring programs and measuring the outcomes and impact of TB programs, indicators for the strengthening of health systems, strengthening of community sy...
With this World Health Day, WHO is drawing attention to a group of diseases that are spread by insects and other vectors, the heavy health and economic burdens they impose, and what needs to be done to reduce these burdens. Many of these diseases have been historically confined to distinct geographi...
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant...
Following the high-level meeting of the UN General Assembly on antimicrobial resistance held in September 2016 which called for national, regional and international political commitment to address the issue, member countries agreed on the importance of moving forward to develop national action plans...
Antimicrobials are widely used in food animal production, and use is rapidly increasing.
In an era of growing demand for animal products, there is an increasing trend towards the industrial production of food animals, especially in lower- and middle-income countries (LMICs). One hallmark of this me...
In 2014, an estimated 40 million women of reproductive age were infected with Schistosoma haematobium, S. japonicum and/or S. mansoni. In both 2003 and 2006, the World Health Organization (WHO) recommended that all schistosome-infected pregnant and breastfeeding women be offered treatment, with praz...
This manual is intended to enable WASH practitioners
who work in Mozambique to contribute to the
reduction of WASH-preventable NTDs.
2nd edition - Published in 2003, the first WHO/HAI medicine prices manual Medicine Prices – A
New Approach to Measurement Draft for field-testing provides a draft methodology and tools to conduct national medicine prices and availability surveys. This second edition of the survey manual has been...
Antimicrobial resistance (AMR) is a major public health challenge, which is recognized as high priority area by the Government of India. The increasing consumption of antibiotics is one of the key drivers of antimicrobial resistance seen in bugs of public health importance. Irrational prescription o...
The global burden of disease (GBD) study provides information about fatal and non-fatal health outcomes around the world.
The objective of this work is to describe the burden of mental disorders among children aged 5–14 years in each of the six regions of the World Health Organisation. Data come ...
Technical Note on Antimicrobial Resistance
This document reflects UNICEF’s response to the growing global threat of AMR to child survival, growth and development. It identifies UNICEF’s AMR-specific and AMR-sensitive actions in reducing infections, promoting access to and optimal use of antimic...
Accountability for the global health sector strategies, 2016–2021
WHO/CDS/HIV/19.7
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial ...
